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Summary. The aim of this study was to investigate the importance of inhibin in the
delay in return to oestrus in heifers induced by steroid-stripped bovine follicular
fluid (bFF). Oestrous activity was synchronized in 18 Hereford \m=x\Friesian heifers
with two injections of prostaglandin (PG) 12 days apart. At the time of the second
PG injection (time 0), the animals were assigned at random to one of three exper-
imental groups and received i.v. injections of 20 ml saline (controls, n = 6), whole
bFF (FF group, n = 6) or bFF in which the bioactive inhibin content had been
reduced by >95% by immunoaffinity chromatography (-INH group, n = 6; inhibin
content \m=approx\0\m=.\8ml whole bFF) every 8 h for 2 days. In a dose\p=n-\responsestudy, 2\m=.\5ml
whole bFF was insufficient to delay oestrus consistently following a similar synchro-
nization regimen. Blood samples were taken every 8 h, initially before each injection
and then subsequently for a further 9 days for hormone analysis. Animals were
observed every 8 h throughout the experiment for signs of behavioural oestrus. The
ovaries of all animals were examined using real-time ultrasonography about 30 h
after the second PG injection.
Treatment failed to suppress peripheral follicle-stimulating hormone (FSH) con-
centrations, although a significant increase was observed in both treatment groups
after cessation of injections. Progesterone concentrations fell immediately after the
second PG injection in all animals and remained below minimum detectable concen-
trations in all treated animals for the remainder of the experiment. In control animals,
progesterone rose above minimum detectable concentrations by day 6 and continued to
rise until the end of the experiment. Analysis of samples taken from treated animals
several days after observed oestrus revealed that all had apparently ovulated. Mean
daily luteinizing hormone (LH) concentrations did not differ between treatment groups
before ovulation, but after ovulation, mean daily LH was significantly reduced in
control animals as progesterone concentrations rose.
Follicular development, as assessed by the mean antral diameter of the largest
follicle on a pair of ovaries at ultrasound examination, was significantly suppressed in
treated animals compared with controls (P < 0\m=.\01)and there was no significant differ-
ence (P = 0\m=.\397)between the two treatment groups. Control animals displayed oestrus
68 h ( \m=+-\8 sem) after the second PG injection, but oestrus was delayed in treated animals
to 186 h \m=+-\5 (FF group) and 191 h \m=+-\6 (-INH group).
We conclude that the suppression of follicular development and the subsequent
delay in return to oestrus associated with bFF treatment of cattle is not due to inhibin.
Furthermore, the data suggest that the rebound of FSH concentrations following bFF
treatment is similarly due to a factor other than inhibin.
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Introduction
The administration of steroid-free bovine follicular fluid (bFF) to cattle or sheep at about the time
of progesterone withdrawal results in a marked increase in the length of time to the return of
oestrus owing to a suppression of follicular development (Miller et al, 1979, 1982; McNeilly, 1984,
1985; Johnson & Smith, 1985; Wallace & McNeilly, 1985, 1986; Henderson et al, 1986; Quirk &
Fortune, 1986). In sheep, this follicular suppression is associated with, and has been attributed to, a
decrease in peripheral concentrations of follicle-stimulating hormone (FSH) (Miller et al, 1982;
McNeilly, 1984; Henderson et al, 1986; Wallace & McNeilly, 1986; Hunter et al, 1988). As the
majority of the FSH-suppressing activity in steroid-stripped bFF is due to its inhibin content(Muttukrishna & Knight, 1990), this delay in return to oestrus has been assumed to be due to the
indirect action of inhibin on follicular growth. However, in intact cattle, Johnson & Smith (1985)
could not demonstrate a suppression of FSH, in spite of a distinct delay in oestrus. Using smaller
groups of animals, Quirk & Fortune (1986) suggested that reduced FSH was the reason for the
delay in return to oestrus, but the changes in FSH seen during treatment were the same in both
control and bFF-treated animals. Price & Webb (1988) have also demonstrated that steroids alone
are the major components involved in the negative feedback regulation of FSH and luteinizing
hormone (LH) secretion in heifers, whereas in sheep a protein component of follicular fluid (pre¬
sumably inhibin) is required for the full regulation of FSH concentrations (Martin et al, 1986,
1988). This questions whether an inhibin-induced FSH-mediated action of bFF is operative in
intact heifers.
In addition, several studies using hypophysectomized ewes treated with pregnant mares' serum
gonadotrophin (PMSG) have suggested that follicular fluid proteins may act at the level of the
ovary to suppress follicular growth directly (Cahill, 1984; Cahill et al, 1985; Larson et al, 1987). In
the light of these observations, we have investigated the importance of inhibin in the bFF-induced
delay in return to oestrus after prostaglandin treatment in heifers. A preliminary report of these
data has been presented elsewhere (Law et al, 1990).
Materials and Methods
Protocol
The animals used in the experiments were 2-year-old Hereford  Friesian heifers. All were housed indoors at the
Large Animal Unit of the Institute of Animal Physiology and Genetics Research, Roslin and were kept together
throughout the experiment. They were maintained on a diet of hay and concentrates and fresh water was available
ad libitum. Oestrous activity was synchronized in all animals with two i.m. injections containing 500 pg of a potent
prostaglandin F2a analogue, cloprostenol (Estrumate: ICI pic, Macclesfield, Cheshire) given 12 days apart. At the time
of the second PG injection (day 0), the animals were assigned at random to the experimental groups for treatment.
In a dose-response experiment (Expt 1), 24 animals were assigned to one of four experimental groups and each
received i.v. injections of either 10 ml saline (control group,  = 6) or 2-5 ml (n = 6), 5 ml (n = 6) or 10 ml (n = 6)
steroid-free bFF every 8 h for 2 days, commencing at the time of the second prostaglandin injection.
In Expt 2, 18 animals were assigned to one of three experimental groups and each received i.v. injections of saline(control group,  = 6), whole bFF (FF group, « = 6) or bFF, the inhibin content of which had been greatly reduced(-INH group, « = 6). As the material had been diluted during elution from the affinity column, each follicular fluid
injection contained the protein equivalent of 20 ml untreated follicular fluid, twice the dose found in Expt 1 to delay
oestrus consistently, diluted to 40 ml with saline. Control injections consisted of 40 ml saline. Injections were adminis¬
tered every 8 h for 2 days, commencing at the time of the second prostaglandin injection. Blood samples were also
taken every 8 h immediately before each injection, starting at the beginning of treatment and continuing for 11 days.
Serum was stored at
—
20°C to await assay.
Animals were observed every 8 h for signs of oestrus; oestrus detection was aided by the use of a commercial heat
detection device (Kamar Tags: Kamar Inc., Steamboat Springs, Colorado). In addition, during Expt 2, the ovaries of
all animals were examined using real time ultrasonography on day 2 to examine the effects of treatment on the size of
the largest follicle in an animal.
Preparation of follicular fluid
Follicular fluid was aspirated from all non-cystic follicles visible on bovine ovaries obtained from the local abattoir
and stored frozen at
—
20°C until required for further use. Since Tsonis et al. (1983) have shown that higher concen¬
trations of charcoal remove inhibin-like activity, batches of bFF were pooled and treated with 1 mg charcoal with
01 mg Dextran per ml overnight at 4°C before centrifugation for 1 h at 2000 g to remove approximately 99% of
steroids. The steroid-free bFF was then stored frozen in 25 ml aliquots in readiness for affinity extraction.
Immunoaffinity extraction of follicular fluid
Mouse ascitic fluid antibody precipitated by ammonium sulfate was dissolved in 01 molNaHC03l ' pH 8-5,
dialysed against 01 mol NaHC03l "' with at least six changes of dialysate, and coupled with an equal volume of an
agarose gel (Affi-Gel 10; Bio-Rad, Sydney, Australia) according to the manufacturer's instructions. The gel was
packed in a column 1-5 cm in diameter to about 7 cm depth. Inhibin was removed from bFF by affinity extraction
using a monoclonal antibody to the 32 kDa bovine inhibin (256H; Miyamoto et al., 1986). The extraction procedure
was as follows. The column was equilibrated with a five times bed volume of 005 mol phosphate buffer 1 ' pH 7-5
containing 9 g NaCl  ' (PBS). Typically, 25 ml bFF was loaded onto the column and washed through with PBS, and
the protein-containing eluate was collected as inhibin-free bFF. The inhibin bound to the column was eluted with
01 mol glycine-HCl 1 "' pH 20 containing 001% PMSF and was immediately neutralized with a one-fifth volume of
2molTris-HCl f pH 8-5. The column was rapidly neutralized with a twice gel volume of 01 molTris-HCll_1 pH 90
and subsequently regenerated by washing with a three times gel volume of 6 mol guanidine-HCl 1 ' followed by
re-equilibration with 0-1 mol Tris-HCl 1 ' pH 9-0. The column was then stored at 4°C overnight. These latter regen¬
eration steps are important in maintaining the efficacy of the column.
Control bFF was processed through a similar immunoaffinity column to which a monoclonal antibody to chicken
growth hormone (6F5; Goddard et al., 1987) had been coupled. This antibody has been extensively characterized and
shown not to bind bovine growth hormone. Subsequent elution of this column with the 01 mol glycine-HCl 1"'
solution failed to elicit a protein peak.
Electrophoresis and immunoblotting of the follicular fluid preparations
Follicular fluid proteins were separated by SDS-PAGE under non-reducing conditions using a 10-15% gradient
gel on the Phast-System (Pharmacia Ltd, Milton Keynes) according to the manufacturer's instructions (Technique
File No. 110). Transfer of proteins onto nitrocellulose filters was performed using the Multiphor II system(Pharmacia). Blots were eluted for 90 min at 32 mA per blot using a Tris-glycine-methanol (pH 8-6) buffer system.
Rainbow protein markers of low molecular mass (14-200 kDa; Amersham) were also run as standards. After transfer,
the filters were blocked with 5% (w/v) Marvel (Cadbury) in PBS (Blotto; 6x5 min changes) and then incubated
for 16 h with a specific antibody raised in rabbits against a synthetic 26 amino acid amino-terminus fragment
of the 32 kDa porcine a-inhibin subunit (R150; McNeilly et al., 1989). The filters were further washed with Blotto
as above and then incubated with a donkey anti-rabbit antibody conjugated to horse-radish peroxidase (SAPU,
Carluke, Lanarkshire) for 2 h at room temperature. Blots were subsequently rewashed with Blotto, developed
with chloro-1-naphthol (3 mg ml" ') in methanol and quenched in water.
Hormone assays
FSH was determined using the homologous double antibody radioimmunoassay system described by Bolt &
Rollins (1983). All samples were measured in a single assay. The sensitivity of the assay, taken to be the dose of
hormone required to suppress the binding of labelled hormone significantly below that observed in zero standards was
0-75 ng per tube (3-OOngml·1) and the within assay coefficient of variation calculated over the whole assay was
16-2%.
LH was similarly determined using a conventional double antibody radioimmunoassay routinely used in this
laboratory (Price & Webb, 1988). All samples were measured in a single assay with a mean intra-assay coefficient of
variation calculated over the whole assay of 111%.
Progesterone was assayed directly in a single assay, using a modification of the radioimmunoassay routinely used
in this laboratory (Price & Webb, 1988). Steroids were dissociated from plasma binding proteins by the inclusion of
100 ng 8-anilino-l-naphthalenesulfonic acid per assay tube. The crossreactivities of various steroids were as pre¬
viously reported (Corrie et al., 1981) and progesterone added to plasma samples was recovered with a mean efficiency
of 102% (±1-38 sem). The sensitivity of the assay was 7-8 pg per tube (0-16 ng ml· ') and the within assay coefficient of
variation was 13-2%.
Oestradiol was assayed in pooled daily samples using the affinity extraction procedure described by Webb et al.(1985). All samples were assayed in a single assay with a mean extraction efficiency of 5805 ± 001%. The sensitivity
of the assay was 1-2 pg per tube and the within assay coefficient of variation was 13-9%.
Inhibin bioactivity was estimated by the ability of a sample to suppress basal FSH release from dispersed ovine
pituitary cells in culture using the procedure of Tsonis et a!. (1986), but with the addition of 10 ng RU486 ml·1 plus a
highly specific oestradiol antisera (Land et al., 1982) at a dilution of 1:50 000 to prevent any possible steroid inter¬
ference. All media used in the cell culture procedure were obtained from Northumbria Biologicals Ltd. The lamb
serum and donor bovine serum were obtained from Flow Laboratories, Rickmansworth, Hertfordshire. All samples,
including the reference preparation, were stripped of steroids by incubation with 1 mg charcoal ml·1 plus 01 mg
dextran ml·' overnight at 4°C and centrifugation for 1 h at 2000#, a process that removes approximately 99% of
steroids (Wallace & McNeilly, 1985). This was followed by passage down a Sep-Pak CK cartridge (Waters Division,
Millipore Corp.) which removed >95% of the remaining steroids. All were subsequently sterilized by ultrafiltration
through a 0-22 pm filter (pStar: Costar Corporation, Cambridge, MA) and diluted as required in supplemented
medium before inclusion in the assay.
Inhibin immunoactivity was determined as described previously (McNeilly et al., 1989). The samples were assayed
in a single assay with an intra-assay coefficient of variation of 14-2%.
Statistical analysis
Unless stated otherwise, the data are presented as arithmetic means + SEM. Comparison of hormone profiles
between groups was carried out by anova, allowing for repeated measurements. Between-group comparisons of
follicle diameter were performed using Student's / test and time to return of oestrus was analysed by means of the
Mann-Whitney-Wilcoxon test.
Results
Experiment 1: dose—response study
All control animals exhibited behavioural oestrus within 4 days of the second PG injection with
a mean interval to oestrus of 75 h ( ± 7 h; sem). Oestrus was not significantly delayed (P > 005
using both anova and
 2 test) in animals treated with 2-5 ml (113 ± 28 h; sem) or 5 ml bFF(139 ± 22 h; sem) per injection, although the delay in oestrus approached significance (P = 00547)
in the higher dose group. Oestrus was uniformly and significantly (P < 0005) delayed in all
animals treated with 10 ml bFF per injection (191 + 6 h; sem).
Experiment 2: effect of removal of inhibin
Characterization offollicularfluidpools. Electrophoretic analysis of the fraction of bFF retained
on the anti-inhibin column revealed the presence of multiple bands of staining differing in molecu¬
lar mass (see Fig. 1). Western blots of the bFF fraction retained on the column (see Fig. 2), using a
specific antibody raised against a portion of the inhibin  subunit (McNeilly et al, 1989) confirmed
that the major band was inhibin of 32 kDa. Other bands corresponded to the multiple molecular
mass species of inhibin initially described by Miyamoto et al (1986), as well as to the 'free' mono-
meric
 
subunits known to be present in bFF (Knight et al, 1989; Robertson et al, 1989; Sugino
et al, 1989). Adsorption of the first inhibin antibody with inhibin (porcine l-26a) prevented
binding, thus confirming the specificity. The inhibin bioassay demonstrated that the inhibin-free
follicular fluid fraction, with a bioactivity of 560 iu ml ' ( ± 75 iu ml~ '), contained less than 3% of
the activity of a control follicular fluid pool (22 200 + 530 iu ml1). Immunoactive inhibin
measurements confirmed that the inhibin activity in the bFF had been significantly reduced from
532 + 45ng pl-26aml_l to 78+ 14ngml"' after the chromatography process. The higher
amount of immunoactive inhibin (15%) compared with bioactive inhibin (<3%) is presumably
due to the interference of the 'free' inhibin a-subunit in the radioimmunoassay.
Oestrus. All control animals exhibited behavioural oestrus within four days of the second PG
injection with a mean interval to oestrus of 68 h (±8 h; sem). Oestrus was uniformly and signifi¬
cantly (P < 0001) delayed in both treatment groups to 186 + 5 h (FF group; +sem) and 191 + 6 h
(-INH group; +sem) after PG. There was no difference (P > 005) between the two treatment
groups.
Fig. 1. Electrophoretic analysis of the fraction of bovine follicular fluid retained on the inhibin
affinity column (lane 2). Molecular mass markers were run in lane 1 and the molecular masses
of the individual markers are shown.
Follicle size. The mean diameter of the largest follicle on a pair of ovaries after one day of
treatment was not significantly different (P > 005) between the two follicular fluid treatment
groups (7-5 ± 0-4 mm versus 8-5 ± 0-9 mm; -INH versus FF groups), but the mean diameter of the
largest follicle in the saline-treated control group of animals was significantly greater (P < 001)
than that seen in the combined treatment groups (11 ± 0-9 mm versus 8-1 ± 0-5 mm; controls
versus all treated animals).
Progesterone concentrations. Progesterone concentrations fell rapidly to below minimum
detectable values in all animals after the second PG injection (Fig. 3a). A steady and sustained
increase was observed in control animals, commencing on day 6 and continuing to the end of the
sampling period. Progesterone remained below minimum detectable concentrations in all animals
in both treatment groups. Samples taken from treated animals on day 16 revealed that pro¬
gesterone concentrations had risen significantly above minimum detectable values by this time
(data not shown).
Oestradiol concentrations. After PG injection at time 0, oestradiol concentrations rose rapidly in
control animals, reaching a peak at about the time of onset of oestrus in these animals (Fig. 3b).
After oestrus, oestradiol fell rapidly to basal values and then subsequently rose to reach a second,
smaller peak concentration at about day 8-9. In treated animals, oestradiol concentrations were
initially suppressed below those seen in controls, but rose to a peak at about day 8-9, again coinci¬
dent with the onset of oestrus in these animals. The amplitude of the pre-ovulatory peak of oestra¬
diol in treated animals did not differ between treatments, but was significantly (P < 001) smaller
than that seen in saline-treated controls.
Fig. 2. SDS-PAGE/immunoblot of affinity purified inhibins from bovine follicular fluid. Lane
1: immunoblotted with rabbit anti-pl-26a inhibin; lane 2: immunoblotted with rabbit anti-pl-
26a inhibin absorbed with pi-26a conjugate. Lane 3: immunoblotted with donkey anti-rabbit
horseradish peroxidase conjugate alone.
LH concentrations. Mean LH concentrations were initially high in all groups, but fell in control
animals to values significantly lower (P < 0-01) than either treatment group by day 6, remaining so
for the remainder of the sampling period (Fig. 4).
FSH concentrations. FSH concentrations fell throughout the experimental period in all groups,
including the controls (Fig. 5), but at no point during the treatment period were concentrations in
treatment groups significantly different from those observed in control animals. After the cessation
of injections, FSH concentrations increased in both experimental groups reaching values signifi¬
cantly higher than those in the respective treatment period (P < 001) and control values
(P < 0-05). After this increase, FSH concentrations then returned to values similar to those seen in
controls. There was no significant difference in FSH profiles between the -INH and the FF groups
at any time during the experiment.
Discussion
These results demonstrate that treatment of heifers with steroid-free bFF delays the onset of
oestrus following prostaglandin injection as previously reported (Miller et al, 1979; Johnson &
Smith, 1985; Quirk & Fortune, 1986) but, importantly, that the delay in oestrus does not depend on
the inhibin content of the follicular fluid. Furthermore, they also show that the delay in oestrus is
not due to a failure of luteolysis, an observation previously confirmed in both cattle and sheep
(Miller et al, 1979; Johnson & Smith, 1985; Quirk & Fortune, 1986). Rather it involves a suppression
of follicular development, as evidenced by the peripheral oestradiol concentrations reported in this
and previous reports (Johnson & Smith, 1985; Quirk & Fortune, 1986), and confirmed by the
ultrasound data. A similar ultrasound-monitored suppression of follicular development by bFF at
various times throughout the oestrous cycle has also been reported (Kasteite et al, 1990).
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Fig. 3. (a) Meandailyprogesteroneconcentrations and (b) mean dailyoestradiol concentrations in
heifers treated with saline (control group, O ), steroid-free bovine follicular fluid (FF group, D ) or
steroid and inhibin-free bovine follicular fluid (-INH group,  ) after prostaglandin injection.
It has been suggested that, in sheep, the bFF-induced suppression of follicular development is
due to an inhibin-mediated suppression of FSH secretion (Miller et al, 1982; McNeilly, 1984;
Wallace & McNeilly, 1985, 1986; Henderson et al., 1986; Hunter et al, 1988). However, in the
present study in intact cattle, no such suppression of FSH secretion was observed. In addition,
there was no difference in response to treatment with either intact, or 'inhibin-free' follicular fluid.
To our knowledge there is only one previous publication, using a smaller number of animals,
reporting FSH concentrations following bFF treatment of intact adult cows at a similar stage of the
oestrous cycle (Quirk & Fortune, 1986). These authors claimed that the delay in oestrus was due to
a reduction in FSH. However, FSH concentrations in treated animals were lower than those in
controls before treatment started. Also in animals treated with 20 ml bFF for 24 h at 6 h intervals, a
rebound of FSH appeared to have started before the last injection and without any preceding
decrease in FSH. This apparent lack of effect of bFF treatment on circulating FSH concentrations
is also supported by the finding that FSH can be maintained in the normal range in ovariectomized
heifers with oestradiol and progesterone alone (Price & Webb, 1988), unlike the case in sheep(Martin et al, 1988). Furthermore, it has been demonstrated that there is an inverse relationship
between the amount of oestradiol and intact inhibin, as measured by a highly specific two-site
immunoradiometric assay for dimeric inhibin, in follicular fluid (Beard et al, 1991). As most of the
Fig. 4. Mean daily concentrations of luteinizing hormone (LH) in heifers treated with (a) saline(control group), (b) steroid-free bovine follicular fluid (FF group) or (c) steroid and inhibin-
free bovine follicular fluid (-INH group) after prostaglandin injection at day 0. The shaded area
represents the mean ± the standard deviation of the control group.
oestradiol emanates from the dominant follicle (Staigmiller et al, 1982), this questions further the
role of inhibin in the control of FSH in intact adult females.
Follicular fluid contains at least one other protein with FSH-suppressing activity, namely
follistatin (Robertson et al, 1987; Ueno et al, 1987). However, its potency is considerably less than
that of inhibin (Robertson et al, 1990), and co-incubation with specific anti-inhibin antisera com¬
pletely abolishes the FSH-suppressive action of bFF in ovine pituitary cell cultures (Muttukrishna
& Knight, 1990). Removal of the majority of the inhibin from follicular fluid would therefore be
expected to remove the major part of any FSH-suppressing activity. The ability of the inhibin-free
bFF to delay oestrus in this experiment would therefore suggest that the action of bFF in delaying
oestrus is not related to its inhibin content. A recent report has also demonstrated that removal of
Fig. 5. Mean concentrations of follicle-stimulating hormone (FSH) in blood samples taken
every eight hours from heifers treated with (a) saline (control group), (b) steroid-free bovine
follicular fluid (FF group) or (c) steroid and inhibin-free bovine follicular fluid (-INH group)
after prostaglandin injection on day 0. The arrows indicate the timing of each follicular fluid or
saline injection. The shaded area represents the mean + the standard deviation of the control
group.
92% of the inhibin activity from bFF does not reduce its ability to suppress follicular development
and delay oestrus in sheep (Campbell et al, 1991). Immunoaffinity extraction of the bFF removed
more than 95% of the inhibin in this study; the remaining activity was therefore equivalent to less
than 1 ml whole bFF inhibin per injection. Since 2-5 ml of bFF in Expt 1 did not consistently delay
oestrus, it is highly unlikely that the residual inhibin had any effect. In addition, Quirk & Fortune
(1986) have previously failed to delay oestrus in half their animals using a dose of 10 ml bFF twice a
day. Furthermore, bovine pituitary cells have been shown to be unresponsive to inhibin-containing
preparations in vitro (Knight, 1991; A. S. Law & R. Webb, unpublished observations). The weight
of evidence therefore suggests that the principal action of bFF in delaying oestrus in cattle is not
mediated either by inhibin or through a reduced pituitary secretion of FSH.
One possible alternative mechanism by which bFF treatment may inhibit follicular develop¬
ment is through a reduction in LH concentrations. The repeated injection of LH alone into
anoestrous sheep is clearly sufficient to overcome the hormonal inadequacies in this experimental
model (McNeilly et al, 1982), at least in breeds that have a shallow anoestrus, confirming that a
reduced LH secretion can influence follicular development. However, mean daily LH concen¬
trations were unaffected by follicular fluid treatment in either this or other experiments (Miller
et al, 1982; Johnson & Smith, 1985; Quirk & Fortune, 1986). In addition, Picton et al (1990) have
demonstrated that basal LH is sufficient to support multiple follicular development in sheep.
Furthermore, although pulsatile LH secretion was not measured in this study, other work has
shown that LH pulse amplitude is actually increased by follicular fluid treatment (Wallace &
McNeilly, 1986; Law, 1991). A mode of action involving a suppression of LH release therefore
seems unlikely. However, Picton et al (1990) have reported that increased LH pulse amplitude is
detrimental to follicular development; this observation warrants further investigation.
Given that treatment failed to alter the mean concentration of either gonadotrophin, it is worthy
of note that oestradiol secretion was significantly suppressed in treated animals. This observation
suggests that the principal effect of follicular fluid treatment, rather than being mediated via a
reduction in gonadotrophin concentrations per se, may involve a reduction in follicular responsive¬
ness to gonadotrophins. Indeed, evidence to support a direct ovarian action of bFF has already
been documented in sheep; several groups using hypophysectomized ewes have demonstrated that
bFF will suppress follicular development in the face of controlled PMSG treatment (Cahill, 1984;
Cahill et al, 1985; Larson et al, 1987). Furthermore, Fry et al. (1987), using a similar model, have
suggested that changes in gonadotrophin concentrations are not involved in the phenomenon of
compensatory ovarian hypertrophy after unilateral ovariectomy. It would therefore appear that
ovarian follicular proteins can act to suppress the development of other follicles in some manner
independent of gonadotrophin concentrations.
The nature of the protein responsible for this action is uncertain. There are many proteins in
follicular fluid, several of which have been characterized as having effects on the development and
function of ovarian cells both in vivo and in vitro. The presence in bovine and porcine follicular fluid
of a protein factor that was produced by the granulosa cells, and which prevented compen¬
satory ovarian hypertrophy in mice has been described (Sato & Ishibashi, 1977, 1978; Sato et al,
1978). Similarly the ovary containing the preovulatory follicle secretes a protein, follicle-regulatory
protein (FRP; diZerega et al, 1982), which is produced by the granulosa cells (diZerega et al,
1983a; Tonetta et al, 1988) and which reduces the responsiveness of other follicles to gonado¬
trophins (diZerega et al, 1982, 1983b). Injection of porcine FRP suppressed follicular development
in cyclic monkeys (diZerega & Wilks, 1984) and guinea-pigs (Fujimori et al, 1987). Other authors
have also reported that porcine and bovine follicular fluid contain several factors that inhibit the
binding of FSH to its receptor (Sluss et al, 1983, 1987, 1989; Sluss & Reichert, 1984a), although
this activity may be the result of bacterial action (Sluss & Reichert, 1984b). Of particular note is the
observation that the precursors of the a-inhibin molecule influence FSH binding and activity in
vitro (Schneyer et al, 1991), given that the inhibin-free bFF in this study was shown to contain
some residual free a-inhibin subunit immunoactivity. Any one or more of these follicular fluid
components may be responsible for the observed effects of bFF treatment. The exact nature of the
active principle awaits further research.
Of additional interest is the observation of a 'rebound' increase in the secretion of FSH despite
the absence of any prior suppression, in agreement with the findings of Johnson & Smith (1985).
The similarity of the rebound between intact and inhibin-stripped bFF-treated groups suggests that
the rebound is not due to an action of inhibin. Campbell et al (1991) have also confirmed that this
rebound of FSH is not mediated by inhibin in sheep. The timing of the FSH rebound in relation to
the cessation of treatment suggests that another bFF protein, rather than inhibin, is involved in the
negative feedback regulation of FSH. The maintenance of FSH concentrations in the face of
reduced ovarian oestradiol production during the treatment period would further suggest that the
action of the putative bFF factor is to increase the sensitivity of the pituitary gland to steroid
negative feedback. These observations also warrant further investigation.
Waves of follicles develop regularly throughout the oestrous cycle (Sirois & Fortune, 1988;
Savio et al, 1988, 1990), but only the dominant follicle of the final wave ovulâtes. The process of
ovulation presumably removes the factors responsible for the dominance of the ovulatory follicle
and allows the initiation of the first non-ovulatory wave. The cessation ofbFF treatment in this study
was approximately coincident with the timing of oestrus and ovulation in the saline-treated control
animals. The coincidental rise in oestradiol secretion in all groups from days 5 to 6 may therefore reflect
a similar withdrawal of follicular suppression in all groups, suggesting that the factor(s) responsible
for bFF-induced suppression of follicular development and follicular dominance are the same.
Interestingly, the size of the preovulatory peak of oestradiol was lower in both bFF-treated
groups than in saline-treated controls. However, it was clearly sufficient to elicit oestrous behaviour
and trigger the endocrine events leading to luteinization. The reasons for this reduced oestradiol
secretion are not immediately apparent. Possibly the prolonged 'follicular phase' caused by the
bFF treatment following the fall in progesterone at luteolysis resulted in an increase in the sensi¬
tivity of the hypothalamus/pituitary gland to oestradiol, and hence a premature initiation of the
gonadotrophin surge, thus preventing the normal rise in oestradiol concentrations. Progesterone
treatment has previously been demonstrated to delay the onset of the preovulatory gonadotrophin
surge in GnRH-treated anoestrous ewes (McLeod et al, 1982). Alternatively, the reduced oestra¬
diol secretion may be due to a direct action of the prior bFF treatment on the developing follicle.
The dominant follicle of the primate ovarian cycle exerts effects on non-dominant follicles that
remain even after ablation of the dominant follicle (diZerega & Hodgen, 1980). Possibly such
effects remained following bFF treatment in this study.
In conclusion, the action of bFF in suppressing follicular development is a direct effect, and is
not mediated via reduced FSH concentrations. The activity is not related to the inhibin content of
follicular fluid. Furthermore, the hypersécrétion of FSH observed following bFF treatment is like¬
wise not due to inhibin, and is not dependent on a prior suppression of FSH. The patterns of
oestradiol and FSH concentrations in relation to the timing of the bFF treatment suggest a
potentiating effect of non-inhibin bFF proteins on the negative feedback effects of oestradiol. These
results further suggest that the mechanism of follicular dominance does not involve a selective
reduction in FSH concentrations.
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monoclonal antibodies, and D. Bolt of the USDA for reagents used in the assays.
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